Study and Treatment of Inflammatory Muscle Diseases [clinicaltrials:NCT00001265]
Study and Treatment of Inflammatory Muscle Diseases [clinicaltrials:NCT00001265]
Bio2RDF identifier
NCT00001265
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001265
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
99,999,999
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This study of inflammat ...... of treatment recommendations.
brief title [clinicaltrials_vocabulary:brief-title]
Study and Treatment of Inflammatory Muscle Diseases
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Polymyositis, dermatomy ...... understanding muscle disease.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Autoimmune Diseases
Connective Tissue Diseases
Dermatomyositis
Idiopathic Inflammatory Myopathies
Inclusion Body Myositis
Pathogenesis
Polymyositis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-07-31T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001265
official title [clinicaltrials_vocabulary:official-title]
Studies on the Natural History ...... myositis, and Related Diseases
org study id [clinicaltrials_vocabulary:org-study-id]
overall contact [clinicaltrials_vocabulary:overall-contact]
overall contact backup [clinicaltrials_vocabulary:overall-contact-backup]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
91-AR-0196
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1991-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-01-01T00:00:00Z
identifier
clinicaltrials:NCT00001265
title
Study and Treatment of Inflammatory Muscle Diseases
@en
type
label
Study and Treatment of Inflammatory Muscle Diseases [clinicaltrials:NCT00001265]
@en